SFDA Launches Electronic Integration Project To Improve Drug Safety In Hospitals

The Saudi Food and Drug Authority (SFDA) has initiated an electronic integration project for Risk Minimization Measures (RMMs) with several hospitals. This was announced by SFDA Chief Executive Dr. Hisham S. Aljadhey during the Global Health Exhibition at the Riyadh Convention and Exhibition Center in Malham, held from October 27 to 30 under the theme "Invest in Health."

The project involves King Fahad Medical City, King Saud Medical City, Security Forces Hospital, King Abdulaziz Medical City, and Johns Hopkins Aramco Healthcare. These hospitals are now equipped to directly enhance patient safety regarding medication use through effective delivery of risk minimization measures.

This initiative positions these hospitals among top healthcare facilities committed to best practices in medicine safety. The RMMs integration is a national effort by SFDA to improve the safe use of high-risk medicines. It provides educational resources and guidance for healthcare professionals and patients to reduce serious adverse effects.

The project aims to incorporate Additional Risk Minimization Measures (aRMMs) into hospitals’ electronic drug-dispensing systems. This ensures that targeted healthcare professionals and patients receive these measures, enhancing implementation and promoting safe pharmaceutical use.

A key goal is to significantly increase awareness among healthcare professionals about potential dangers associated with high-risk medicines. The SFDA reported that the first three phases of the project, conducted from 2023 to 2025, showed notable improvements in physicians’ awareness of risk minimization measures.

These phases also facilitated easier access to these measures for both patients and healthcare practitioners. The integration project underscores SFDA’s commitment to advancing patient safety and ensuring effective medication management across Saudi Arabia’s healthcare system.

With inputs from SPA